Back to Authors

Dorigo, Oliver

https://orcid.org/0000-0002-1976-5201

A5074884103 | I97018004

Mayo Clinic

Stanford University

Citations 13

636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials

Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A727-A728

10.1136/jitc-2023-sitc2023.0636

Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease

JAMA Oncology | January 20, 2022 | Volume: 8 | Issue: 4 | Pages: 618

10.1001/jamaoncol.2021.7148 | PMID 35050310

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network | November 7, 2019 | Volume: 17 | Issue: 11 | Pages: 1374-1391

10.6004/jnccn.2019.0053 | PMID 31693991

Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.